Zobrazeno 1 - 10
of 341
pro vyhledávání: '"E Wiltshaw"'
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Louk V.A.M. Beex, Jan B. Vermorken, Ignace Vergote, Desmond Curran, E. Wiltshaw, Sergio Pecorelli, H.C. Wagenaar
Publikováno v:
European journal of cancer
The aim of this study was to investigate the clinical activity and toxicity of a modified PVB regimen (cisplatin, vinblastine and bleomycin) in patients with advanced or recurrent, pure granulosa cell tumours (GCTs) or mixed granulosa-theca cell tumo
Autor:
Lesley A. Stewart, S. B. Kaye, S. Pecorelli, N. Colombo, C. Mangioni, R. V. Smalley, B. Y. Yeap, D. W. Wilbur, R. C. Leonard, M. F. Brady, E. Wiltshaw, P. F. Conte, S. Marsoni, J. F.G. Sturgeon, M. H.N. Tattersall, C. Gennatas, C. Trope, A. Athanazziou, D. Guthrie, D. Crowther, D. R. Bell, A. H. Laing, M. Gore, J. B. Vermorken, C. Lewis, E. Gilbey, Giorgio Bolis, H. Bruckner, P. Adnitt, M. K.B. Parmar, M. Tomirotti, H. Meerpohl, H. S. Brodovsky, W. Sauerbrei, J. Pater, R. Canetta, W.W. ten Bokkel Huinink, D. V. Skarlos, H. J. Solomon, M. J. Webb, J. T. Wharton, F. Landoni, P. Y. Liu, M. M. Turbow, J. H. Edmonson, D. S. Alberts, C. J. Cohen, K. Aabo, W. Torri, V. Barley, M. Adams, M. Buyse, C. J. Williams, M. Presti, V. Chylak, U. Bianchi, G. A. Omura
Publikováno v:
Scopus-Elsevier
The purpose of this systematic study was to provide an up to date and reliable quantitative summary of the relative benefits of various types of chemotherapy (non-platinum vs platinum, single-agent vs combination and carboplatin vs cisplatin) in the
Publikováno v:
The Teaching Cases from Annals of Oncology ISBN: 9780792341178
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::bf5c0ec5a02a928412e79d8829ad2a61
https://doi.org/10.1007/978-94-011-5456-7_17
https://doi.org/10.1007/978-94-011-5456-7_17
Autor:
T J, Perren, E, Wiltshaw, P, Harper, M, Slevin, R, Stein, S, Tan, M, Gore, I J, Fryatt, P R, Blake
Publikováno v:
British Journal of Cancer
In a study designed to compare response rates of patients with stage III epithelial ovarian carcinoma to ifosfamide and carboplatin, 152 patients were randomised to receive either sequential therapy with three cycles of ifosfamide followed by three c
Publikováno v:
Cancer chemotherapy and pharmacology. 31
Two trials using ifosfamide-based combination chemotherapy for advanced soft-tissue sarcoma have been completed. In the first study, 50 evaluable patients received ifosfamide (5 g/m2) with mesna (5 g/m2) and doxorubicin (40 or 60 mg/m2) intravenously
Publikováno v:
Cancer. 69(9)
Metastases from cystosarcoma phyllodes are rare, and treatment generally is ineffective. Four patients were treated with ifosfamide (alone in three and combined with doxorubicin in one). Two patients had complete remissions that lasted 26 and 61+ mon
Publikováno v:
Gynecologic oncology. 45(2)
Publikováno v:
Cancer. 69(1)
A retrospective study of 33 patients with cystosarcoma phyllodes was done. Eight of these patients had metastases, and the clinical and histologic criteria predicting the development of metastases were examined. The most reliable predictor was the pr
Autor:
Grant B. Williams (Chairman), R. T. D. OLIVER, E. S. NEWLANDS, E. WILTSHAW, J. S. MALPAS, E. Wiltshaw, J. S. Malpas, E. Newlands, R. T. D. Oliver, M. Alderson, H. J. G. Bloom, H. T. Ford, W. F. Hendry, R. J. Shearer, P. A. Trott, R. Sandland, H. Whitfield, N. Howard, P. F. Philip, J. Boyd, M. Snell, R. Durrant, G. Fellows, J. C. Smith, P. R. Riddle, G. F. Abercrombie, I. Cede, J. Vinnicombe, A. G. Turner
Publikováno v:
British Journal of Urology. 53:444-447
Summary— A series of 27 patients with measurable metastases from primary carcinoma of the bladder received cis-platinum 50 mg/m2/3-weekly. Twenty-six per cent (32% if patients receiving only one injection are excluded) responded for a median of 4 m